RPL22L1 and malignant colon neoplasm: Likewise, shRNA knockdown of RPL22L1 decreased proliferation of colon cancer lines HCT116 and HT29 (Fig 2D and S2B and S2C Fig), and the anchorage-independent cell growth of SW620, HT29 and HCT116 (Fig 2E–2G).